The Genotyping Assay Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Genotyping Assay Market:
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
According to The Business Research Company’s Genotyping Assay Global Market
Report 2024, The genotyping assay market size has grown exponentially in recent
years. It will grow from $27.7 billion in 2023 to $33.98 billion in 2024 at a
compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be
attributed to traditional glassware usage, cultural and lifestyle influences,
economic factors, hospitality and foodservice industry growth, gift and decor
trends.
The genotyping assay market size is expected to see exponential growth in the
next few years. It will grow to $77.77 billion in 2028 at a compound annual
growth rate (CAGR) of 23.0%. The growth in the forecast period can be
attributed to customization and personalization, health and wellness trends,
e-commerce growth, smart and functional glassware, culinary and mixology
trends. Major trends in the forecast period include material innovation,
innovative shapes and designs, smart glassware, specialized glassware for
beverages, health and safety features.
The increasing prevalence of genetic disorders is expected to propel the growth
of the genotyping assay market going forward. Genetic disorders are a group of
medical conditions that are caused by abnormalities or mutations in an
individual's deoxyribonucleic acid (DNA). Genotyping assays compare the DNA of
affected people to that of healthy people to spot changes and can reveal
specific genetic mutations or variations linked to a particular genetic
disorder. For instance, in June 2023, Gene People, a UK-based registered
charity organization supporting individuals with genetic conditions, reported
that one in every 25 children in the UK had a genetic disorder, affecting
approximately 30,000 newborns and young children in the country as well as more
than 2.4 million children and adults annually. Therefore, the increasing
prevalence of genetic disorders is driving the growth of the genotyping assay
market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp
The genotyping assay market covered in this report is segmented –
1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments,
Bioinformatics
2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary
Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight
Mass Spectrometry, Other Technologies
3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal
Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories,
Academic Institutes
Major companies operating in the genotyping assay market are developing
advancements in genomic research such as CE-IVD marked assay to detect
treatment-resistant strains of HIV-1. CE-IVD marked Applied Biosystems TaqPath
Seq HIV-1 Genotyping Kit refers to a Sanger sequencing-based assay that examines
positive samples of human immunodeficiency virus (HIV) to identify genetic
variants that may resist common antiretroviral therapeutics. For instance, in
January 2023, Thermo Fisher Scientific, a US-based company launched CE-IVD
marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This system detects
treatment-resistant strains of HIV-1 and has unique features that include
assessing genomic mutations, using HIV RNA, detecting drug resistance
mutations, using gold-standard Sanger sequencing technology, and is designed
for clinical use. The launch of the Applied Biosystems TaqPath Seq HIV-1
Genotyping Kit has added value by improving the detection of
treatment-resistant HIV-1 strains, providing ready-to-use reagents and
controls, meeting regulatory requirements, having high-performance
characteristics, and being compatible with existing sequencing platforms and
workflows.
The genotyping assay market report table of contents includes:
1. Executive Summary
2.
Genotyping Assay Market Characteristics
3.
Genotyping Assay Market Trends And Strategies
4.
Genotyping Assay Market - Macro Economic Scenario
5. Global
Genotyping Assay Market Size and Growth
.
32. Global Genotyping Assay Market Competitive Benchmarking
33. Global
Genotyping Assay Market Competitive Dashboard
34. Key
Mergers And Acquisitions In The Genotyping Assay Market
35.
Genotyping Assay Market Future Outlook and Potential Analysis
36.
Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment